Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Microarray Technology Enables Sequencing of Neanderthal DNA

By LabMedica International staff writers
Posted on 20 May 2010
By utilizing an advanced DNA capture technique, genomic researchers have succeeding in mapping a portion of the Neanderthal genome and comparing it to that of modern humans.

Investigators at the Max Planck Institute (Munich, Germany) , Cold Spring Harbor Laboratory (Cold Spring Harbor, NY, USA), and Agilent Technologies, Inc. More...
(Santa Clara, CA, USA) used Agilent's microarray system to sequence nearly 14,000 protein-coding positions inferred to have changed on the human lineage since the last common ancestor shared with chimpanzees.

Generally, it has been extremely difficult to work with ancient DNA due in part to chemical aging of the DNA molecules but even more so due to severe bacterial contamination of the samples. Now, in a study published in the May 7, 2010, issue of the journal Science, investigators from the three institutions described the use of array-hybridization capture technology, a process that enriched Neanderthal DNA sequences while depleting contaminant DNA. Thus, they were able to enrich Neanderthal protein-coding regions where differences occurred on the human evolutionary lineage up to 190,000-fold. By generating the sequence of one Neanderthal and 50 present-day humans, the investigators identified 88 amino acid substitutions that have become fixed in humans since our divergence from the Neanderthals.

"Attaining good coverage of the Neanderthal genome had been a problem due to DNA contamination from microbes over the years,” said senior investigator Dr. Svante Paabo, professor of evolutionary genetics at the Max Planck Institute. "Simply sequencing, without first enriching for the genome, often did not work, especially where the contamination levels were high. Array-hybridization capture technology was originally reported by the Cold Spring Harbor Laboratory group and is the subject of a longstanding collaboration with Agilent. The team recognized this as a promising method for recovering large regions of targeted sequence from Neanderthal samples. The method can also be used more widely with many other kinds of human remains.”

In a second article in the same issue of Science, the investigators presented their first detailed analysis of the draft sequence of the Neanderthal genome, which now includes more than three billion nucleotides collected from the bones of three female Neanderthals who lived in Croatia more than 38,000 years ago. By comparing this composite Neanderthal genome with the complete genomes of five living humans from different parts of the world, the investigators found that both Europeans and Asians share 1-4% of their nuclear DNA with Neanderthals, but that Africans do not. This suggests that early modern humans interbred with Neanderthals after moderns left Africa, but before they spread into Asia and Europe.

Related Links:

Max Planck Institute
Cold Spring Harbor Laboratory
Agilent Technologies



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Collection and Transport System
PurSafe Plus®
New
Hemodynamic System Monitor
OptoMonitor
New
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Ultrasensitive NeXT Personal Test detects the earliest molecular signs of recurrence in breast cancer patients (Photo courtesy of Personalis)

Ultrasensitive Test Could Identify Earliest Molecular Signs of Metastatic Relapse in Breast Cancer Patients

HR+ (hormone receptor-positive) HER2- (human epidermal growth factor receptor 2-negative) breast cancer represents over 70% of all breast cancer cases and carries a significant risk of late recurrence.... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.